Related Experiment Videos
Advances in high content screening for drug discovery
Kenneth A Giuliano1, Jeffrey R Haskins, D Lansing Taylor
1Cellomics, Inc., Pittsburgh, Pennsylvania 15219, USA. kgiulliano@cellomics.com
Assay and Drug Development Technologies
|April 20, 2004
Summary
High-content screening (HCS) has revolutionized drug discovery by integrating automated microscopy, image analysis, and bioinformatics. This technology accelerates target validation, screening, and lead optimization through advanced cell-based assays.
Area of Science:
- Cellular Biology
- Drug Discovery
- Biotechnology
Background:
- High-content screening (HCS) has transformed traditional drug discovery workflows.
- Early HCS platforms were instrument-focused, requiring significant researcher interaction.
- HCS integrates automated microscopy, plate handling, and image analysis.
Purpose of the Study:
- To review the evolution of HCS in drug discovery.
- To demonstrate how recent HCS advances accelerate the drug discovery pipeline.
- To present a real-world use case of HCS in drug discovery.
Main Methods:
- Review of HCS technological advancements.
- Integration of assay design, automated instrumentation, and bioinformatics.
- Application of HCS in a drug discovery workflow use case.
Main Results:
- HCS enables cell-based target validation, secondary screening, and lead optimization.
- Modern HCS platforms offer integrated solutions for accelerated drug discovery.
- BioApplication software and informatics solutions generate actionable knowledge from cell image data.
Conclusions:
- HCS has evolved into a comprehensive solution for efficient drug discovery.
- The integration of HCS components streamlines the entire drug discovery process.
- HCS facilitates the globalization of drug discovery efforts within organizations.